Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis

Clinical trial NCT05540938 · RECRUITING

Trial details

NCT number: NCT05540938
Sponsor: China-Japan Friendship Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2023-05-23
Primary completion: 2025-12-31
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.